We are monitoring the impact of COVID-19 on APAC Precision Medicine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1401
Share on
Share on

Asia Pacific Precision Medicine Market Research Report – Segmented By Technology, Application, By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1401
Pages: 145

As Per the Report, the Asia Pacific Precision Medicine Market was valued at USD 11.08 Billion in 2020 and is projected to reach USD 19.96 Billion by 2025, at a CAGR of 12.5% during the forecast period.

Precision Medicine is the ability to classify individuals into subpopulations that differ in their susceptibility to a particular disease, in the biology and/or prognosis of those diseases they may develop, or in their response to a specific treatment.

The market for Precision Medicine is mainly driven due to recent research advances that have helped expand benefits to various aspects of healthcare by enabling a better understanding of disease mechanisms, assessment of disease risks and prediction of optimal therapy. But, the market growth can be restrained due to risks of data sharing and governmental regulations and standards on medicines, devices, and treatments.

This research report has been segmented and sub-segmented into the following categories:

  • By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics and Others.
  • By Application: Oncology, CNS, Immunology, Respiratory and Others.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Regional Analysis

Indian precision medicine market is holding with significant shares in the APAC market. Growing incidences of various infectious diseases is certainly a major for the market to grow in this country. Rise in the prevalence to improve the healthcare infrastructure is elevating the growth rate of the market. According to the Indian Council of Medical Research, over 17 million new cases are seen per year. Thus there is a large scope for precision medicine in India.

The Chinese market is one of the leading countries in the research of precision medicine. Increasing geriatric population is greatly influencing the demand of the market. The rising number of clinical trials on developing a vaccine to control the spreadCOVID-19 of this outbreak is escalating the demand of the market. 

In Japan, the market size is growing following China. The rise in the scale of research and development activities is prompting the growth rate of the market. Japans National Cancer Center is conducting various projects on developing precision medicine for cancer.

Australian precision medicine market is esteemed to have prominent shares in coming years. Innovation and Science Australia has identified the benefit of using genomics and precision medicine. Escalating expenditure on healthcare and rise in demand for the quality health services are boosting up the growth rate of the market. 

The Korean government said to invest 55.7 million USD on developing precision medicine. The ministry of science and ICT has launched a precision medicine promotion body with the Korean University Medical Applied R&D Global Initiative Center. This is propelling the growth of the market. 

Major companies operating in the APAC Precision Medicine Market are Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics, are the major players of North America Precision Medicine market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Big Data Analytics

                                5.1.3 Bioinformatics       

                                5.1.4 Gene Sequencing

                                5.1.5 Drug Discovery      

                                5.1.6 Companion Diagnostics     

                                5.1.7 Others      

                                5.1.8 Y-o-Y Growth Analysis, By Technology         

                                5.1.9 Market Attractiveness Analysis, By Technology       

                                5.1.10 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 CNS            

                                5.2.4 Immunology          

                                5.2.5 Respiratory             

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8 Market Attractiveness Analysis, By Application        

                                5.2.9 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By Indication

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Application

                                                6.1.4.5 By Indication

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By Indication

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Pfizer                            

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Roche                           

                8.3 Covance                      

                8.4 Novartis                       

                8.5 Qiagen                         

                8.6 Biocrates Life Sciences                          

                8.7 Teva Pharmaceutical                              

                8.8 Nanostring Technologies                      

                8.9 Laboratory Corporation of America Holdings                

                8.10 Medtronic                

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  2. Asia-Pacific Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  3. Asia-Pacific Big Data Analytics Market, By Region, From 2020 to 2025 (USD Billion)
  4. Asia-Pacific Bioinformatics Market, By Region, From 2020 to 2025 (USD Billion)
  5. Asia-Pacific Gene Sequencing Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia-Pacific Drug Discovery Market, By Region, From 2020 to 2025 (USD Billion)
  7. Asia-Pacific Companion Diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  8. Asia-Pacific Other Precision Medicine Technologies Market, By Region, From 2020 to 2025 (USD Billion)
  9. Asia-Pacific Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  10. Asia-Pacific Oncology Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  11. Asia-Pacific CNS Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  12. Asia-Pacific Immunology Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  13. Asia-Pacific Respiratory Precision Medicine Market, By Region, From 2020 to 2025 (USD Billion)
  14. Asia-Pacific Other Precision Medicine Applications Market, By Region, From 2020 to 2025 (USD Billion)
  15. China Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  16. China Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  17. India Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  18. India Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  19. Japan Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  20. Japan Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  21. South Korea Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  22. South Korea Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)
  23. Australia Precision Medicine Market, By Technology, From 2020 to 2025 (USD Billion)
  24. Australia Precision Medicine Market, By Application, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample